$2.760
+0.468 (+16.95%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CNTB por análisis de gráficos similares
Alphio's CNTB stock price prediction model matches the current Connect Biopharma Holdings Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.75 (-0.44%). The 1-week path is $2.63 (-4.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Connect Biopharma Holdings Ltd?
Connect Biopharma Holdings Ltd is a good buy right now due to its upcoming Phase 2 trial results for Rademikibart, expected to be a significant catalyst for the stock. The current price is $2.23, and analysts have set price targets of $6 to $8, indicating substantial upside potential of 169% to 259%. Additionally, the stock has a forward P/E ratio of 0.7669, suggesting it is undervalued compared to its future earnings potential. However, the main risk is the company's negative net income, which was -$17,284,000 in the latest quarter, indicating ongoing financial challenges that investors should monitor closely.
CNTB cerró en $2.76 el Wednesday, tras subir +16.95%
Connect Biopharma Holdings Ltd (CNTB) last closed at $2.76, gaining +16.95%. These facts feed the 1-day and 1-week CNTB price prediction above.
Factores de la previsión
Los factores de la previsión de Connect Biopharma Holdings Ltd (CNTB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CNTB, ordenadas por similitud.
Análisis de estacionalidad de CNTB
Historically the probability of a positive September return for CNTB is 77.27%. October offers the highest probability of a positive month at 82.61%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CNTB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.71 | $1.80 | $1.96 | -34.93% |
| Oct 2026 | $1.68 | $1.82 | $2.16 | -34.07% |
| Nov 2026 | $1.62 | $1.85 | $2.19 | -32.88% |
| Dec 2026 | $1.53 | $1.56 | $1.88 | -43.57% |
En 2026, se proyecta que Connect Biopharma Holdings Ltd (CNTB) oscile entre $1.53 y $2.19.
Previsión mensual de Connect Biopharma Holdings Ltd para 2026
En Sep de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.80, con un mínimo de $1.71 y un máximo de $1.96.
En Oct de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.82, con un mínimo de $1.68 y un máximo de $2.16.
En Nov de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.85, con un mínimo de $1.62 y un máximo de $2.19.
En Dec de 2026, se proyecta que Connect Biopharma Holdings Ltd promedie $1.56, con un mínimo de $1.53 y un máximo de $1.88.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.